These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20637371)

  • 1. NAT2 polymorphism and gastric cancer susceptibility: a meta-analysis.
    Zhong X; Hui C; Xiao-Ling W; Yan L; Na L
    Arch Med Res; 2010 May; 41(4):275-80. PubMed ID: 20637371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley.
    Malik MA; Upadhyay R; Modi DR; Zargar SA; Mittal B
    Arch Med Res; 2009 Jul; 40(5):416-23. PubMed ID: 19766908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer.
    Ochs-Balcom HM; Wiesner G; Elston RC
    Am J Epidemiol; 2007 Aug; 166(3):246-54. PubMed ID: 17535831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.
    Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma.
    Betti M; Neri M; Ferrante D; Landi S; Biava A; Gemignani F; Bertolotti M; Mirabelli D; Padoan M; Ugolini D; Botta M; Bonassi S; Magnani C; Dianzani I
    Int J Hyg Environ Health; 2009 May; 212(3):322-9. PubMed ID: 18838334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
    Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
    Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the relationship between NAT2 polymorphism and colorectal cancer susceptibility.
    Liu H; Fu ZX; Wang CY; Qian J; Xing L; Liu YW
    Medicina (Kaunas); 2012; 48(3):117-31. PubMed ID: 22588343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Invest; 2007 Aug; 25(5):340-6. PubMed ID: 17661210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
    Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.
    Srivastava DS; Mittal RD
    BMC Urol; 2005 Aug; 5():12. PubMed ID: 16083506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAT2 polymorphism and lung cancer risk: a meta-analysis.
    Cui D; Wang Z; Zhao E; Ma J; Lu W
    Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.